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Abstract
We evaluated the treatment results and aortic remodeling of Stanford type B aortic dissection 
（TBAD） following thoracic endovascular aortic repair （TEVAR） to determine the optimal timing 
to operate.  Based on the duration from the onset of TBAD to surgery, 17 patients who 
underwent TEVAR for TBAD were divided into early （n＝10, TEVAR＜3 months from onset） 
and late （n＝7, TEVAR≥3 months from onset） groups.  True- and false-lumen areas were 
measured at four levels （A-D） using contrast-enhanced computed tomography before and 
after TEVAR : A, immediately after the left subclavian artery branching ; B, descending aorta at 
the tracheal bifurcation ; C, aortic annulus ; and D, diaphragm.  The durations from the onset 
of TBAD to TEVAR were 46±25 days and 7.0±5.3 years in the early and late groups, 
respectively.  No major intraoperative complications were observed in either group.  However, 
the early group had one case of retrograde type A aortic dissection 54 days after TEVAR.  In 
the early group, true-lumen area increased at all levels, except at level A, whereas false-lumen 
areas decreased at all levels （p＜ 0.05）.  The late group showed no tendencies, except for an 
increased true-lumen area at level B.  A difference in early aortic remodeling was observed―
true-lumen area enlargement and false-lumen area decrease were more marked in the early 
group than the late group.  TEVAR is useful when performed early after TBAD onset （within 
3 months） and results in good aortic remodeling.  In the late phase, the effect might be 
relatively smaller.
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Introduction
　Conservative treatment is often selected to address 
acute type B aortic dissection （TBAD） unless 
there are serious complications such as rupture or 
organ ischemia.  However, in ～40％ of TBAD 
cases, dissecting aortic aneurysms occur in the long 
term, making treatment difficult1, 2. While false-
lumen perfusion is considered a precursor to adverse 
consequences, complete thrombosis can lead to aortic 
remodeling and improve long-term prognosis.  Early 
intervention in uncomplicated TBAD can lead to 
aortic remodeling by early-entry closure via thoracic 
endovascular aortic repair （TEVAR）3-5.  However, 
there is a risk of complications such as retrograde 
type A aortic dissection （RTAD） and stent graft-
induced new entry （SINE）, and we considered that 
performing TEVAR only in high-risk cases that 
develop dissecting aneurysms during the long-term 
follow-up is better6.  In contrast, a study reported 
that aortic remodeling was obtained even if TEVAR 
was performed in the chronic phase7.  With these 
findings, the optimal timing for TEVAR remains 
unclear.  Therefore, we studied the therapeutic results 
and aortic remodeling to determine the optimal 
timing of TEVAR for TBAD.
Materials and methods
Patients and clinical characteristics
　We examined 40 patients who underwent TEVAR 
for TBAD between April 2014 and October 2019. 
Among them, five had DeBakey IIIa aortic dissection, 
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34 had DeBakey IIIb aortic dissection, and one had 
rupture.  Of the 34 patients with DeBakey IIIb aortic 
dissection, six had the ulcer-like projection type, nine 
had the thrombosed type, 17 had the patent false-
lumen type, and two could not be analyzed.  The 17 
patients with the DeBakey IIIb false-lumen type were 
divided into early group （n＝10） in whom TEVAR 
was performed 46.3 days±25.3 days after the onset of 
TBAD and late group （n＝7） in whom TEVAR was 
performed 7.0±5.3 years （range, 2-16 years） after the 
onset of TBAD.
Adaption and procedures of TEVAR
　Conservative treatment of uncomplicated TBAD 
for 22 days was our first choice according to the 
guidelines8.  Afterward, if the aortic diameter 
at TBAD onset had been＞40 mm or follow-
up computed tomography （CT） showed a rapid 
expansion of the aortic diameter, TEVAR was 
performed.  TEVAR is indicated for patients with an 
aortic diameter of ≥55 mm and those whose aortic 
diameter expanded ≥5 mm within 6 months, which 
indicates chronic TBAD8.
　We have a policy for addressing the proximal 
landing zone that has not been affected by the 
dissected aorta―debranching was added, as necessary. 
Moreover, in cases of aortic dissection, we did not 
perform balloon crimping including in the chronic 
phase even if intraoperative endoleaks were observed 
because there was a risk of aortic rupture.  The 
stent was long enough only to reach the major 
entry and to close off as much as possible the clear 
flow into the false lumen of the descending thoracic 
aorta.  However, to prevent paraplegia, we avoided 
placing the stent farther than the level of the aortic 
annulus.  When selecting the device, we ensured that 
the diameter used on the proximal side was 10％ 
larger than the native diameter.  On the distal side, 
we traced the circumference of the true lumen from 
which we calculated the diameter of the true lumen. 
Next, we selected a stent that was 10％ larger than 
the diameter of the true lumen.  We chose the TAG 
Conformable Thoracic Stent （C-TAG） （W.L. Gore & 
Associates, Inc., Flagstaff, AZ, USA） with an active 
Fig. 1.  Aortic evaluation using the VINCENT system before and after surgery
This case was in the late group, and 4 years after the onset, one debranching thoracic 
endovascular aortic repair was performed due to the enlargement of the aortic system.
A and C are preoperative images showing DeBakey IIIb false-lumen-type chronic aortic 
dissection.
B and D are postoperative images taken on the 26th postoperative day, and good false-lumen 
thrombus was observed.
A : Preoperative computed tomography（CT） （three-dimensional image）.
B : Postoperative CT（three-dimensional image）.
C : Preoperative CT（curved planar reconstruction image）.
D : Postoperative CT（curved planar reconstruction image）.
A B C D
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control because being able to follow it through a 
steep aortic arch in patients with less curvature is 
important to avoid causing a bird beak configuration. 
Before using the C-TAG with an active control, we 
used a C-TAG device without a bare stent on the 
proximal side along with a Valiant system （Medtronic, 
Dublin, Ireland） for its ability to follow along the 
proximal side.  On the distal side, we placed the 
device in a position where avoiding the bent part of 
the descending aorta is possible.  If we identified the 
artery of Adamkiewicz using contrast-enhanced CT, 
the device was placed without touching the artery of 
Adamkiewicz.
Radiological evaluations
 Approximately 1 week after surgery, contrast-
enhanced CT was performed to detect any endoleaks, 
intimal damage, thrombosis in the false lumen, 
and reentry patency.  To evaluate remodeling of 
aortic aneurysms, we measured the true- and false-
lumen areas at the following levels : A, immediately 
after branching of the left subclavian artery ; B, the 
descending aorta at the tracheal bifurcation level ; C, 
the descending aorta at the aortic annulus level ; and 
D, the descending aorta at the diaphragm level （Fig. 
1 and 2）.
Fig. 2.  Measurement of true- and false-lumen areas at each level before and after surgery
The true-lumen and false-lumen areas at each level of CT images of the same patient as in 
Figure 1. Postoperative false-lumen thrombus, enlargement of the true-lumen area, and reduction of 
the false-lumen area are observed.
Four levels for evaluation（top to bottom）.
A : Immediately after branching of the left subclavian artery.
B : The descending aorta at the tracheal bifurcation level.
C : The descending aorta at the aortic annulus level.
D : The descending aorta at the diaphragm level.
Four levels, A-D, preoperatively
Left : Preoperative
Four levels, A-D, postoperatively
Right : Postoperative
A A
B B
C C
D D
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Statistical evaluation
　The data are presented as means±standard 
deviations.  For statistical analysis, we used the 
t-test and P values of＜0.05 were used to indicate 
statistical significance.
Ethical consideration
　Our institutional review board （IRB） approved 
this study and waived the requirement for written 
informed consent.  The ethics approval number 
for this study was F2020C38 at the IRB of Showa 
University Fujigaoka Hospital.
Results
Clinical characteristics
　The rate of having a preoperative history of 
hypertension was high in both groups.  No difference 
regarding the proportion of patients having diabetes, 
renal dysfunction, respiratory dysfunction, and 
cerebrovascular disorder was present between the 
groups （Table 1）.
Periprocedural details of TEVAR
　We adopted the classification proposed by Ishimaru 
et al.9 Among the 10 patients （seven men ; mean age, 
60±16 years） in the early group, seven underwent zone 
3 TEVAR and three underwent zone 2 TEVAR with 
axillo-axillary （Ax–Ax） bypass （Table 2）.  The mean 
diameter of the aortic aneurysms at the onset was 
41.7±6.3 mm （Table 1）.  Three patients underwent 
TEVAR during their conservative treatment period 
for an enlarged aneurysm diameter （n＝1）, enlarged 
aneurysm diameter and uncontrollable pain （n＝
1）, and asymptomatic superior mesenteric artery 
narrowing （n＝1）.  One patient with an aortic 
diameter of 27 mm underwent TEVAR because 
of intermittent claudication and a decreased ankle/
brachial pressure index during follow-up as a 
complication of TBAD.  In six of the seven patients, 
the aortic diameter exceeded 40 mm after conservative 
treatment for 22 days after TBAD onset, with the 
operation performed during the subacute stage.
　All patients in the late group were men （mean 
age, 52±10 years）, four of who underwent zone 3 
TEVAR and three underwent zone 2 TEVAR with 
Ax–Ax bypass （Table 2）.  The mean diameter of the 
aortic aneurysms at the time of TEVAR was 54.9±  
7.2 mm.  Three-chamber dissection was performed 
in two cases.  We performed the “candy plug” 
technique10 in two cases to suppress the retrograde 
false-lumen blood flow from the abdominal aorta.
　The durations from the onset of TBAD to TEVAR 
were 46±25 days and 7.0±5.3 years in the early and 
late groups, respectively.  The operation times were 
121±76 min and 176±65 min （p＝0.16） in the early 
and late groups, respectively, and the longer operation 
time in the late group was due to the debranching 
and candy plug procedures.  The mean observation 
periods were 38±26 months and 41±21 months, 
respectively.  The number of stent implantations for 
Table 1.   Comparison of the patients’ preoperative clinical characteristics between the early and 
late groups
Early group
（n＝10）
Late group
（n＝7） P value
Age 60±16 years 52±10 years 0.30
Day from onset 46±25 days 7.0±5.3 years 0.01
Diameter at the time of TEVAR 41.7±6.3 mm 54.9±7.2 mm ＜0.01
Sex （male） 7 （70％） 7 （100％） 0.12
Prior CVA 1 （10％） 0 （0％） 0.42
Previous open surgery 0 （0％） 1 （14％） 0.24
Diabetes mellitus 0 （0％） 0 （0％） 0
Hypertension 6 （60％） 6 （14％） 0.28
CKD （Cr＞1.5） 0 （0％） 0 （0％） 0
Respiratory dysfunction （FEV1.0％＜70％） 2 （20％） 1 （14％） 0.78
Bronchial asthma 1 （10％） 1 （14％） 0.80
Rheumatism 1 （10％） 0 （0％） 0.42
CVA, cardiovascular accident ; CKD, chronic kidney disease ; Cr, creatinine ; FEV1.0％, forced 
expiratory volume 1.0％ / forced vital capacity ratio ; TEVAR, thoracic endovascular aortic repair.
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the two groups was 1.4±0.5 and 2.0±0.5, respectively 
（Table 2）.  The grafts used included C-TAG （n＝
8）, Valiant （n＝1）, and Zenith Dissection （Cook 
Group, Indiana, USA） （n＝1） in the early group 
and C-TAG （n＝4）, Valiant （n＝1）, and Zenith 
Dissection （n＝2） in the late group.
　We performed zone 2 TEVAR following Ax–Ax 
bypass in all cases and embolized the left subclavian 
artery.  To prevent paraplegia, we maintained the 
mean blood pressure at ≥90 mmHg during the 
operation, and the stent insertion site was adjusted to 
the level of the aortic annulus as much as possible. 
In the late group, one patient underwent stent graft 
insertion to the tracheal bifurcation level, and a bare 
stent was inserted onto the distal side using the 
Provisional Extension to Induce Complete Attachment 
technique11.
Radiological evaluations of TBAD pre- and post-
TEVAR
　In all patients, the mean time to postoperative CT 
was 7±2 days.  In the early group, the true-lumen 
area was significantly increased at all levels, except 
for the A level―B : 381 mm2±201 mm2 to 576 mm2
±164 mm2 （p＜0.01）; C : 266 mm2±112 mm2 to 
471 mm2±120 mm2 （p＜0.01）; and D : 231 mm2±
157 mm2 to 357 mm2±162 mm2 （p＜0.01）.  Moreover, 
the false-lumen area was significantly reduced at all 
levels―A : 306 mm2±238 mm2 to 116 mm2±147 mm2 
（p＝0.02）; B : 671 mm2±242 mm2 to 541 mm2±
309 mm2 （p＝0.05）; C : 665 mm2±197 mm2 to 
530 mm2±217 mm2 （p＝0.01）; and D : 532 mm2±
173 mm2 to 432 mm2±140 mm2 （p＜0.01）.  In the 
late group, the true-lumen area did not increase, 
except for the true-lumen area at the B level―B : 
339 mm2±70 mm2 to 448 mm2±70 mm2 （p＝0.03） 
（Table 3 and Fig. 3）.  The early group had a greater 
increase in the true-lumen area and reduction in the 
false-lumen area than the late group.
Complications and prognosis
　No intraoperative or early postoperative intimal 
injuries ; transition to thoracotomy ; and postoperative 
paraplegia, cerebral infarction, or hospital deaths 
were encountered.  However, intraoperative access 
causing vascular injury was observed in one case.  We 
achieved entry closure in all cases, and all patients 
were discharged without requiring re-surgery or 
experiencing in-hospital death.
　There was no case of SINE during the course. 
In the early group, one patient who underwent 
zone 2 TEVAR with Ax–Ax bypass using a Valiant 
stent complained of chest pain after discharge and 
developed an RTAD.  In this patient, TEVAR was 
performed 62 days after the TBAD onset.  During 
reoperation, the bare stent was stuck in the intima, 
suggesting that the bare stent was involved in the 
development of RTAD in this case.
　Thrombosis of the false lumen was obtained in all 
cases at the left subclavian artery level.  In patients 
with reentry patency, thrombosis of the false lumen 
was not obtained beyond the tracheal bifurcation 
Table 2.   Comparison of the surgical details and intraoperative complications between the early 
and late groups
Early group
（n＝10）
Late group
（n＝7） P value
C-TAG 8 4 0.34
Valiant 1 1 0.80
Zenith dissection 1 2 0.35
Candy plug 0 2 0.80
Operation time 121±76 min 176±65 min 0.16
Proximal landing zone Zone 3 TEVAR 7 4 0.61
Zone 2 TEVAR 3 3 0.61
Zone 1 TEVAR 0 0
Zone 0 TEVAR 0 0
Distal landing zone Tracheal bifurcation level 1 0 0.42
Aortic valve level 5 5 0.41
Diaphragm level 2 2 0.70
Access route complication 0 1 0.24
C-TAG, TAG Conformable Thoracic Stent ; TEVAR, thoracic endovascular aortic repair.
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level because the retrograde false-lumen blood flow 
remained.  In the case of reentry closure, thrombosis 
occurred over the entire false lumen.
Discussion
　Acute TBAD with severe complications （e.g., 
rupture, refractory pain, and organ malperfusion 
Fig. 3.   Preoperative and postoperative evaluation of the true- and false-lumen areas at each 
level in the early and late groups
Bars A-D in the figure are immediately after left subclavian artery branching（A）, the descending 
aorta at the tracheal bifurcation（B）, the aortic annulus（C）, and the diaphragm（D）, respectively. 
The vertical axis of each figure represents the area（mm2）.
Figures A and B are graphs showing changes in the true-lumen（Fig. A） and false-lumen areas
（Fig. B） before and after surgery in the early group.  Figures C and D are graphs showing 
changes in the true-lumen（Fig. C） and false-lumen areas（Fig. D） before and after surgery in 
the late group.
The expansion of the true-lumen area and reduction of the false-lumen area are remarkable in 
the early group, but not in the late group.
Table 3.   The true- and false-lumen areas of each group
Early group （n＝10） Late group （n＝7）
True-lumen area （mm2） Pre-TEVAR Post-TEVAR P value Pre-TEVAR Post-TEVAR P value P value＊
A 593±188 642±141 0.24 648±163 672±138 0.29 0.56
B 381±201 576±164 ＜0.01 339±70 448±70 0.03 0.63
C 266±112 471±120 ＜0.01 311±76 361±73 0.23 0.40
D 231±157 357±162 ＜0.01 286±85 291±83 0.92 0.44
False-lumen area （mm2） Pre-TEVAR Post-TEVAR P value Pre-TEVAR Post-TEVAR P value P value＊
A 306±238 116±147 0.02 274±287 338±332 0.18 0.82
B 671±242 541±309 0.05 1205±425 1083±448 0.06 0.01
C 665±197 530±217 0.01 1515±768 1284±872 0.32 0.01
D 532±173 432±140 ＜0.01 1054±500 1096±507 0.61 0.01
TEVAR, thoracic endovascular aortic repair.
＊P value for the statistical difference of the pre-TEVAR values between the early and late groups.
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including the lower extremities） is associated with 
a poor prognosis and requires surgical treatment12. 
The factors associated with the poor prognosis of 
acute TBAD regarding long-term results have been 
reported, including an aortic maximum diameter at 
the onset of ≥40 mm13, partial thrombosis of the false 
lumen14, and chronic obstructive pulmonary disease2.  
　The mortality rate following the surgical treatment 
of complicated acute TBAD was 10.1％ according 
to the 2017 Surgical Statistics of the Japanese 
Association for Thoracic Surgery12.  For DeBakey 
IIIb dissection, which creates entry to the distal arch 
aorta, closing the entry using an open stent graft is 
necessary, for which the in-hospital mortality rate is 
16.9％15.  Favorable treatment results for TEVAR, a 
minimally invasive procedure during the acute stage, 
have recently been reported16-19.  Moreover, the 
in-hospital mortality rate, which includes patients with 
branch reconstruction, is 9.1％.  Early closure of the 
entry using TEVAR accelerates aortic remodeling 
and prevents the enlargement of the false lumen5, 
consequently improving the remote prognosis of 
TBAD3, 4.
　Afifi et al. have reported that complicated acute 
TBAD is associated with a significantly higher 
rate of early mortality than uncomplicated acute 
TBAD20.  Several meta-analyses have shown that the 
short- and medium-term prognoses of patients with 
uncomplicated acute TBAD treated with TEVAR 
are satisfactory7, 21, 22.  However, dissecting aortic 
aneurysms appeared in the long term in ～40％ of 
patients who underwent medical treatment during the 
acute phase1, 2.  The overall 5-year mortality rate for 
uncomplicated acute TBAD was 12.8％-13.2％23, 24.
　The timing of TEVAR for uncomplicated TBAD 
currently depends on the facility where it is 
performed.  Desai et al. have reported that patients 
who underwent TEVAR within 2 weeks after 
the onset of TBAD had more fatal complications 
（such as RTAD） in comparison with patients who 
underwent TEVAR during 2-6 weeks after the onset 
of TBAD because of a fragile inner membrane6. 
Moreover, they have reported that if TEVAR is 
performed＞3 months from the onset, true-lumen 
enlargement and aortic remodeling after TEVAR 
may not be sufficient because intimal thickening and 
stiffening continue to progress.  In one of the patients 
in this study, TEVAR was performed within 2 weeks 
following the onset of TBAD.  This case was an 
86-year-old female who had a history of bronchial 
asthma and was receiving steroids.  TEVAR （entry 
closure） was performed using C-TAG to enlarge the 
aneurysm diameter during conservative treatment. 
The patient was discharged home 22 days after 
surgery without major complications.  CT performed 
on the eighth postoperative day showed good aortic 
remodeling.
　According to the VIRTUE registry5, aortic 
remodeling in subacute patients is similar to the 
acute group.  Therefore, we followed the strategy for 
performing TEVAR for uncomplicated TBAD early 
after conservative treatment.  （However, we may have 
to reconsider the stent used and the operative timing, 
as we observed RTAD in a patient in whom TEVAR 
was performed 62 days after the onset of TBAD.） 
Our results have shown that aortic remodeling 
is significant in patients in whom TEVAR was 
performed within 3 months from the onset of TBAD ; 
therefore, performing TEVAR within that period is 
necessary.  Our results were almost the same as those 
of the VIRTUE registry5, which showed that aortic 
remodeling （i.e., a decrease in the false-lumen area） 
was worse during the chronic phase in patients in 
whom TEVAR was performed 6 months after the 
onset of TBAD.  Therefore, we concluded that early 
intervention with TEVAR is effective in the long 
term for patients with uncomplicated TBAD and who 
have poor prognostic factors.  In contrast, effective 
remodeling is possible even in cases wherein TEVAR 
was performed ≥1 year after the onset of the 
disease7.  In this study, a reduction of the false-lumen 
area at the C level was observed in three patients in 
the late group.  The three patients are early cases in 
the late group （the period from onset of the disease 
is 23-48 months）.  Even in the late group, there were 
cases of remodeling, particularly the early cases.  We 
discussed that examining the difference between cases 
that are remodeled and cases that are not remodeled 
in the late group is necessary.
　In this study, we examined the frequency of aortic 
remodeling in the early and late groups.  If the 
number of cases increases in the future, we will 
need to examine the predictive factors for aortic 
remodeling by dividing the late group into more 
detailed periods.
　Patients with complete thrombosis of the false 
lumen have a good long-term prognosis13, 18.  In some 
patients with DeBakey IIIb dissection, both entry 
and reentry can be covered using a stent graft, and 
complete thrombosis of the false lumen could be 
easily obtained.  However, covering reentry near the 
abdominal aortic branches is difficult.  We placed the 
stent graft as short a range as possible to prevent 
paraplegic complications ; hence, the insertion was 
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limited to the level of the aortic annulus.  Therefore, 
reentry remained in most cases, and although the 
false-lumen area was significantly reduced in the 
early group, complete false-lumen thrombosis was not 
attained.  If appropriate remodeling is obtained in 
the long term, it may be reduced, but an aneurysm 
could still form at sites where false-lumen thrombosis 
is not complete.  Even if surgery is required, it may 
be possible to respond to a Crawford VI aneurysm 
but not a more widespread Crawford II aneurysm. 
Therefore, we believe that early closure using TEVAR 
is useful.
Limitations of this study
　The first limitation of this study is that it is a 
retrospective study involving a small number of 
cases.  In addition, it is a comparison using only CT 
immediately after surgery.  Half-year and one-year 
remodeling will be an issue for future consideration.
　The second limitation of this study is selection 
bias because TEVAR is a relatively new treatment 
and it has actively intervened in previously followed 
up cases.  The early group underwent TEVAR 
immediately after the onset because TEVAR has 
become widespread in Japan recently and is relatively 
easy to conduct.  The late group postponed the 
TEVAR procedure at the onset of TBAD because 
TEVAR could not be indicated because it is a new 
treatment that has emerged in the last decade.  The 
late group was indicated for treatment because it had 
passed without complications such as aortic rupture 
and re-dissection, but it gradually expanded.
　We should present the CT parameters immediately 
after the onset of TBAD compared with those just 
before TEVAR in the late group.  However, we 
could not present these parameters because many 
patients were diagnosed at another medical institution 
and were referred to us with an aortic diameter 
enlargement, and many of them did not have images 
immediately after the onset of TBAD.
Conclusion
　At present, TEVAR is the first-line treatment for 
complicated acute or chronic TBAD because it is 
minimally invasive and uses advanced devices.  We 
believe that TEVAR is a useful treatment strategy for 
treating dissections when performed early after onset. 
After applying TEVAR, good aortic remodeling was 
obtained within 3 months after the TBAD onset. 
Because the number of cases is small and the result 
is early outcome, further studies and careful follow-up 
of long-term remodeling and prognoses are necessary.
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